Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 5
2018 2
2019 4
2020 3
2021 3
2022 3
2023 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.
The future of oncology therapeutics.
Mansinho A, Boni V, de Miguel M, Calvo E. Mansinho A, et al. Expert Rev Anticancer Ther. 2017 Jul;17(7):563-565. doi: 10.1080/14737140.2017.1331131. Epub 2017 May 22. Expert Rev Anticancer Ther. 2017. PMID: 28504011 No abstract available.
New designs in early clinical drug development.
Mansinho A, Boni V, Miguel M, Calvo E. Mansinho A, et al. Ann Oncol. 2019 Sep 1;30(9):1460-1465. doi: 10.1093/annonc/mdz191. Ann Oncol. 2019. PMID: 31218367 Free article. Review.
Bone metastasis risk factors in breast cancer.
Pulido C, Vendrell I, Ferreira AR, Casimiro S, Mansinho A, Alho I, Costa L. Pulido C, et al. Among authors: mansinho a. Ecancermedicalscience. 2017 Jan 24;11:715. doi: 10.3332/ecancer.2017.715. eCollection 2017. Ecancermedicalscience. 2017. PMID: 28194227 Free PMC article. Review.
RANK Pathway Inhibition Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibitors and Enhances Immune Response.
Gomes I, Martelo M, Vilela RD, Jiménez M, Trinidad EM, Gómez-Miragaya J, González-Suárez E, Martins É, Torres SS, Corredeira P, Miranda JL, Mansinho A, Torres S, Abreu C, Sousa R, Casimiro S, Costa L. Gomes I, et al. Among authors: mansinho a. Mol Cancer Ther. 2025 Nov 3;24(11):1826-1838. doi: 10.1158/1535-7163.MCT-24-1158. Mol Cancer Ther. 2025. PMID: 40444791
Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer.
Cruz-Duarte R, Rebelo de Almeida C, Negrão M, Fernandes A, Borralho P, Sobral D, Gallego-Paez LM, Machado D, Gramaça J, Vílchez J, Xavier AT, Ferreira MG, Miranda AR, Mansinho H, Brito MJ, Pacheco TR, Abreu C, Lucia-Costa A, Mansinho A, Fior R, Costa L, Martins M. Cruz-Duarte R, et al. Among authors: mansinho a. Clin Cancer Res. 2022 Mar 15;28(6):1203-1216. doi: 10.1158/1078-0432.CCR-21-1992. Clin Cancer Res. 2022. PMID: 34980600 Free PMC article.
34 results